From: Cell therapies for chondral defects of the talus: a systematic review
Endpoint | Baseline | Last follow-up | MD | P |
---|---|---|---|---|
VAS | 6.8 ± 2.1 | 2.4 ± 1.7 | − 4.4 | 0.002 |
Tegner | 5.0 ± 2.8 | 5.5 ± 0.7 | 0.5 | 0.4 |
AOFAS | 54.1 ± 6.7 | 85.2 ± 7.2 | 31.1 | 0.0001 |